MEU SOLUTIONS LTD and OAK MEADOWS LIMITED exit Reacta Biotech cap table

MEU SOLUTIONS LTD and OAK MEADOWS LIMITED have exited the cap table of Reacta Biotech Limited, according to the company's latest confirmation statement. Based in Deeside and founded in 2013, Reacta Biotech develops and manufactures GMP-grade oral food-challenge meals for use in food-allergy diagnostics and clinical trial programs. Its products are supplied to pharmaceutical companies and research organisations that conduct food-allergy studies.

The shareholder changes, covering the period to 9 June 2026, show the departure of both entities from the register. OAK MEADOWS LIMITED is also a shareholder in CORTECH HOLDINGS LIMITED. These exits leave the company with a group of established institutional and private investors.

The cap table remains led by DBW INVESTMENTS (3) LIMITED, which holds 598,125 shares. MOULTON GOODIES LIMITED follows as a major shareholder with 543,625 shares. Other investors on the register include MNL NOMINEES LIMITED with 155,787 shares and MNL (BBI) NOMINEES LIMITED with 66,765 shares. MOMOTHYO LIMITED also retains its position on the cap table with a holding of 6,466 shares. These changes were formalised in a filing made on 19 June 2026.